898 abstracts found.



Results filter

Tumour-propagating cells in non-small cell lung cancer

Year:

Session type:

Carla Kim1,
1Children's Hospital Boston, Boston, USA

Stereotactic ablative radiotherapy (SABR): a local therapy poised to fight metastatic cancer

Year:

Session type:

Robert Timmerman1,
1University of Texas Southwestern Medical Center, Dallas, USA

What can we learn from circulating tumour cells in lung cancer – biomarkers, mouse models, drug resistance and heterogeneity

Year:

Session type:

Caroline Dive1,
1Cancer Research UK Manchester Institute, Manchester, UK

Neutral and biased replacement of intestinal stem cells

Year:

Session type:

Doug Winton1,
1Cancer Research UK Cambridge Institute, Cambridge, UK

Proton therapy: pushing the frontiers of radiotherapy

Year:

Session type:

Tony Lomax1,
1Centre for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland

Introduction: Inflammation and cancer

Year:

Session type:

Fran Balkwill1,
1Queen Mary, University of London, London, UK

Introduction: Cancer evolution

Year:

Session type:

Charles Swanton1,2,
1Cancer Research UK London Research Institute, London, UK,2niversity College London Cancer Institute, London, UK

Image guided radiation therapy

Year:

Session type:

Uwe Oelfke1,
1The Institute of Cancer Research UK and The Royal Marsden NHS Foundation Trust, London, UK

The targets for tumour immunotherapy mediated by the inflammatory properties of vesicular stomatitis virus (VSV)-based antigen presentation depend upon the tumour’s anatomical site

Year:

Session type:

Richard Vile1,
1Mayo Clinic, Rochester, USA

Making sense of intratumour heterogeneity: evidence of a ‘Big Bang’ tumour expansion

Year:

Session type:

Andrea Sottoriva1,
1The Institute of Cancer Research, London, UK

Page 2 of 90« First...2...25...Last »